World Journal of Surgery

, Volume 33, Issue 9, pp 1909–1915

Ischemic Preconditioning Confers Antiapoptotic Protection During Major Hepatectomies Performed Under Combined Inflow and Outflow Exclusion of the Liver. A Randomized Clinical Trial

  • Nikolaos Arkadopoulos
  • Georgia Kostopanagiotou
  • Kassiani Theodoraki
  • Charalambos Farantos
  • Theodosios Theodosopoulos
  • Vaia Stafyla
  • John Vassiliou
  • Dionyssios Voros
  • Agathi Pafiti
  • Vassilios Smyrniotis
Article

Abstract

Background

Extensive experimental studies and a few clinical series have shown that ischemic preconditioning (IPC) attenuates oxidative ischemia/reperfusion (I/R) injuries in liver resections performed under inflow vascular control. Selective hepatic vascular exclusion (SHVE) employed during hepatectomies completely deprives the liver of blood flow, as it entails simultaneous clamping of the portal triad and the main hepatic veins. The aim of the present study was to identify whether IPC can also protect hepatocytes during liver resections performed under SHVE.

Methods

Patients undergoing major liver resection were randomly assigned to have either only SHVE (control group, n = 43) or SHVE combined with IPC—10 min of ischemia followed by 15 min of reperfusion before SHVE was applied (IPC group, n = 41).

Results

The two groups were comparable with regard to age, liver resection volume, blood loss and transfusions, warm ischemic time, and total operative time. In liver remnant biopsies obtained 60 min post-reperfusion, IPC patients had significantly fewer cells stained positive by TUNEL compared to controls (19% ± 8% versus 45% ± 12%; p < 0.05). Also IPC patients had attenuated hepatocyte necrosis, systemic inflammatory response, and oxidative stress as manifested by lower postoperative peak values of aspartate transaminase, interleukin-6, interleukin-8, and malondialdehyde compared to controls. Morbidity was similar for the two groups, as were duration of intensive care unit stay and extent of total hospital stay.

Conclusions

In major hepatectomies performed under SHVE, ischemic preconditioning appears to attenuate apoptotic response of the liver remnant, possibly through alteration of inflammatory and oxidative pathways.

References

  1. 1.
    Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–870PubMedCrossRefGoogle Scholar
  2. 2.
    Smyrniotis V, Farantos Ch, Kostopanagiotou G et al (2005) Vascular control during hepatectomy: review of methods and results. World J Surg 29:1384–1396PubMedCrossRefGoogle Scholar
  3. 3.
    Belghiti J, Noun R, Malafosse R et al (1999) Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 229:369–375PubMedCrossRefGoogle Scholar
  4. 4.
    Smyrniotis VE, Kostopanagiotou GG, Lolis E et al (2003) Effects of hepatovenous back flow on ischemia–reperfusion injuries in liver resections with the Pringle maneuver. J Am Coll Surg 197:949–954PubMedCrossRefGoogle Scholar
  5. 5.
    Yoshizumi T, Yanaga K, Soejima Y et al (1998) Amelioration of liver injury by ischemic preconditioning. Br J Surg 85:1636–1640PubMedCrossRefGoogle Scholar
  6. 6.
    Carini R, Albano E (2003) Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125:1480–1491PubMedCrossRefGoogle Scholar
  7. 7.
    Wang NP, Bufkin BL, Nakamura M et al (1999) Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis. Ann Thorac Surg 67:1689–1695PubMedCrossRefGoogle Scholar
  8. 8.
    Glazier SS, O’Rourke DM, Graham DL et al (1994) Induction of ischemic tolerance following brief local ischemia in rat brain. J Cereb Blood Flow Metab 14:545–553PubMedGoogle Scholar
  9. 9.
    Cavalieri B, Perelli MG, Aragno M et al (2002) Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl 8:990–999PubMedCrossRefGoogle Scholar
  10. 10.
    Quireze C, de Souza Montero EF, Cubero Leitão RM et al (2006) Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia–reperfusion injury in the rats. J Invest Surg 19:229–236PubMedCrossRefGoogle Scholar
  11. 11.
    Clavien PA, Yadav S, Sindram D et al (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232:155–162PubMedCrossRefGoogle Scholar
  12. 12.
    Clavien PA, Selzner M, Rüdiger HA et al (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238:843–852PubMedCrossRefGoogle Scholar
  13. 13.
    Azoulay D, Lucidi V, Andreani P et al (2006) Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving caval flow: a randomized prospective study. J Am Coll Surg 202:203–211PubMedCrossRefGoogle Scholar
  14. 14.
    Fukai M, Hayashi T, Yokota R et al (2005) Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med 38:1372–1381PubMedCrossRefGoogle Scholar
  15. 15.
    Peralta C, Hotter G, Closa D et al (1997) Protective effect of preconditioning on the injury associated to hepatic ischemia–reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 25:934–937PubMedCrossRefGoogle Scholar
  16. 16.
    Peralta C, Fernández L, Panés J et al (2001) Preconditioning protects against systemic disorders associated with hepatic ischemia–reperfusion through blockade of tumor necrosis factor–induced P-selectin up-regulation in the rat. Hepatology 33:100–113PubMedCrossRefGoogle Scholar
  17. 17.
    Peralta C, Bartrons R, Riera L et al (2000) Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 279:G163–G171PubMedGoogle Scholar
  18. 18.
    Howell JG, Zibari GB, Brown MF et al (2000) Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 69:300–303PubMedCrossRefGoogle Scholar
  19. 19.
    Peralta C, Closa D, Xaus C et al (1998) Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 28:768–773PubMedCrossRefGoogle Scholar
  20. 20.
    Serafin A, Rosello-Catafau J, Prats N et al (2004) Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39:688–698PubMedCrossRefGoogle Scholar
  21. 21.
    Kim YI, Song KE, Ryeon HK et al (2002) Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection. Hepatogastroenterology 49:1077–1082PubMedGoogle Scholar
  22. 22.
    Arai M, Thurman RG, Lemasters JJ (2001) Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 7:292–299PubMedCrossRefGoogle Scholar
  23. 23.
    Lee WY, Lee SM (2005) Ischemic preconditioning protects post-ischemic oxidative damage to mitochondria in rat liver. Shock 24:370–375PubMedCrossRefGoogle Scholar
  24. 24.
    Rudiger HA, Graf R, Clavien PA (2003) Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J Hepatol 39:972–977PubMedCrossRefGoogle Scholar
  25. 25.
    Izuishi K, Tsung A, Hossain MA et al (2006) Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 44:573–580PubMedCrossRefGoogle Scholar
  26. 26.
    Hu GH, Lu XS (2005) Effect of normothermic liver ischemic preconditioning on the expression of apoptosis-regulating genes C-jun and Bcl-XL in rats. World J Gastroenterol 11:2579–2582PubMedGoogle Scholar
  27. 27.
    Li SQ, Liang LJ, Huang JF et al (2004) Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 10:2580–2584PubMedGoogle Scholar
  28. 28.
    Barrier A, Olaya N, Chiappini F et al (2005) Ischemic preconditioning modulates the expression of several genes, leading to overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 19:1617–1626PubMedCrossRefGoogle Scholar
  29. 29.
    Rudiger HA, Kang KJ, Sindram D et al (2002) Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 235:400–407PubMedCrossRefGoogle Scholar
  30. 30.
    Smyrniotis V, Kostopanagiotou G, Theodoraki K et al (2005) Ischemic preconditioning versus intermittent vascular inflow control during major liver resection in pigs. World J Surg 29:930–934PubMedCrossRefGoogle Scholar
  31. 31.
    Chouker A, Martignoni A, Schauer R et al (2005) Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophilis. Arch Surg 140:129–136PubMedCrossRefGoogle Scholar
  32. 32.
    Nuzzo G, Giuliante F, Vellone M et al (2004) Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 10:S53–S57PubMedCrossRefGoogle Scholar
  33. 33.
    Petrowsky H, McCormack L, Trujillo M et al (2006) A prospective, randomized, trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 244:921–930PubMedCrossRefGoogle Scholar
  34. 34.
    Smyrniotis V, Theodoraki K, Arkadopoulos N et al (2006) Ischemic preconditioning versus intermittent vascular occlusion in liver resections under selective vascular exclusion: a prospective randomized study. Am J Surg 192:669–674PubMedCrossRefGoogle Scholar
  35. 35.
    McCurry KR, Campbell DA Jr, Scales WE et al (1993) Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 55:49–54PubMedCrossRefGoogle Scholar
  36. 36.
    Villarete LH, Remick DG (1997) Nitric oxide regulation of interleukin-8 gene expression. Shock 7:29–35PubMedCrossRefGoogle Scholar
  37. 37.
    Remick DG, Villarete L (1996) Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukoc Biol 59:471–475PubMedGoogle Scholar
  38. 38.
    Yamada T, Hisanaga M, Nakajima Y et al (1999) The serum interleukin 8 level reflects hepatic mitochondrial redox state in hyperthermochemohypoxic isolated liver perfusion with use of a venovenous bypass. Surgery 125:304–314PubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2009

Authors and Affiliations

  • Nikolaos Arkadopoulos
    • 1
  • Georgia Kostopanagiotou
    • 2
  • Kassiani Theodoraki
    • 2
  • Charalambos Farantos
    • 1
  • Theodosios Theodosopoulos
    • 1
  • Vaia Stafyla
    • 1
  • John Vassiliou
    • 1
  • Dionyssios Voros
    • 1
  • Agathi Pafiti
    • 3
  • Vassilios Smyrniotis
    • 1
  1. 1.Second Department of SurgeryUniversity of Athens School of MedicineAthensGreece
  2. 2.First Department of Anesthesiology, Aretaieion HospitalUniversity of Athens School of MedicineAthensGreece
  3. 3.Laboratory of Pathology, Aretaieion HospitalUniversity of Athens School of MedicineAthensGreece

Personalised recommendations